Back to search

Article

Enhancing bacteriophage therapeutics through <i>in situ</i> production and release of heterologous antimicrobial effectors

2022-03-09

Abstract excerpt

Bacteriophages operate via pathogen-specific mechanisms of action distinct from conventional, broad-spectrum antibiotics and are emerging as promising alternatives. However, phage-mediated killing is often limited by bacterial resistance development (1,2). Here, we engineer phages for target-specific effector gene delivery and host-dependent production of colicin-like bacteriocins and cell wall hydrolases. Using u...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
41dc4042-5e42-5982-934c-4fc0fa511a0f
DOI
10.1101/2022.03.09.483629
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enhancing bacteriophage therapeutics through <i>in situ</i> production and release of heterologous antimicrobial effectorsDOI 10.1101/2022.03.09.483629
Select a neighboring publication to make it the new centre.